ADDF, Pfizer’s CTI collaborate to advance advancement of new medications for Alzheimer’s disease The Alzheimer's Drug Discovery Base and Pfizer's Centers for Therapeutic Innovation announced today a collaboration made to advance the development of new small-molecule medicines for Alzheimer's disease and related dementias. As part of the first-of-its kind collaboration in Alzheimer's, the ADDF and CTI will jointly spend money on translational research projects, with a focus on novel Alzheimer's medication targets. The cross-sector alliance is made to enable project groups, comprised of Pfizer scientists and choose academic experts, to translate novel scientific analysis into effective therapeutics for Alzheimer's disease.Furthermore to allowing for extended working period Concert Backbone VR Bone Cement provides the regularity of a even, silky paste, deliverable through a 15 gauge cannula, from initial dispensing to depletion, says Roy Bogert, Abdominal muscles Vice President of R&D. Unlike other bone cements altered from orthopaedic indications, Concert Spine VR Bone Cement was particularly developed to address the issues and requirements regarding the minimally invasive treatment of vertebral compression fractures. The look and future modifications of the Plexis device provide a delivery implies that is minimally invasive while keeping polymers or other materials in controlled suspension for specific qualitative and quantitative placement.